Rheumatic Diseases of Skeletal Muscle Flashcards

1
Q

Types of Myopathies

A
  • Polymyositis
  • Dermatomyositis (amyopathic and juvenile)
  • inclusion body myositis
  • cancer related myositis
  • collagen vascular disease related myositis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Clinical manifestations of inflammatory myopathies

A
  • slowly progressive, fixed proximal muscle weakness
  • premature fatigue
  • elevated muscle CPK
  • post-exertional aches, cramps and pains (chronic myalgias not a primary feature)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Risk factors of inflammatory myopathies

A
  • increased risk of malignancy

- may have arthritis, raynaud’s, pitting edema of the extremities, , pulmonary involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Criteria for defining polymyositis

A
  1. symmetrical weakness of limg-girdle muscles and anterior neck flexors
  2. muscle biopsy evidence of necrosis of Type 1 and 2 fibers, phagocytosis, regeneration, variation in fiber type with inflammatory exudation. –> confirm dignaosis
  3. elevation of serum or skeletal muscle enzymes
  4. EMG triad of short, small, polyphasia motor units, fibrillations and sharp waves; and bizarre, repetitive discharges
  5. dermatologic features
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Classes of Muscle weakness

A

Myopathic = proximal and symmetric. Remainder of neuro exam is normal.

Neuropathic = proximal, distal and/or asymmetric. Other abnormalities on neuro exam.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List types of muscle enzymes you would measure in a patient presenting with muscle weakness

A
  1. CPK (most commonly measured)
  2. aldolase
  3. AST, ALT and LDH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are potential etiology of high CPK levels?

A
  • acute MI
  • racial differences - african americans have higher.
  • trauma = sharp, blunt; EMG needle, biopsy
  • exercise = anaerobic, aerobic
  • drugs = ETOH, cocaine, statins, AZT
  • Carrier = glycogen storage disease, muscular dystrophy, periodic paralysis, malignant hyperthermia
  • large muscle mass
  • asymptomatic (benign) hyper-CK-emia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Muscle enzymes in inflammatory myopathies

A
  • CPK is most commonly followed
  • CPK can be normal
  • CPK is elevated at some point in every patient
  • none of these enzymes correlate well with disease activity.
  • Enzymes can be elevated and people can be asymptomatic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the use of EMG and Nerve conduction studies?

A
  • Differentiate myopathic and neuropathic disorders
  • helps further localize the affected area
  • identify appropriate site for biopsy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the electrophysiologic changes in inflammatory myopathies?

A
  • fibrillation at rest
  • increased insertional activity
  • bizarre high-frequency repetitive discharges
  • polyphasic potentials of short duration and low amplitude
  • spontaneous and positive sharp waves
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are typical patterns of EMG in inflammatory myopathies?

A
  • 40% have classic features
  • normal in 10%
  • abnormalities may be limited to paraspinous muscles
  • neuropathic findings may also be seen in = inclusion body myositis, myositis with anti-SRP antibodies, myositis and malignancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MRI findings in inflammatory myopathies

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Polymyositis

A
  • Cytotoxic CD8 invading muscle fiber
  • invading lymphocytes express CD45Ro (antigen primed memory cells)
  • ICAM-1 expressed on muscle fibers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Components of muscle histology in polymyositis?

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Definition of dermatomyositis

A

polymyositis plus a rash
muscle histology is different
May be more like a paraneoplastic phenomenon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Features of Dermatomyositis

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Classic Rashes and nail findings in Dermatomyositis

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

tissue findings in dermatomyositis

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

histology of dermatomyositis

A

.

20
Q

Compare pathologic features of polymyositis vs dermatomyositis

A

.

21
Q

Describe auto-antibodies and pulmonary disease features of polymyositis and dermatomyosits

A

.

22
Q

List to auto-antibodies features found with polymyositis and dermatomyositis

A

.

23
Q

Describe anti-synthetase syndrome and implications in polymyositis or dermatomyositis

A

.

24
Q

CT Scan lung findings

A

honeycombing and fibrosis

25
Q

Pulmonary manifestations

A

.

26
Q

Describe the connection between malignancy and myositis

A

.

27
Q

What are the subsets of sermatomyositis?

A

.

28
Q

Describe juvenile dermatomyositis

A

.

29
Q

Describe amyopathic dermatomyositis

A

.

30
Q

What are potential treatment options for polymyositis and dermatomyositis?

A

.

31
Q

What is the clinical presentation of inclusion body myositis?

A

.

32
Q

What are the tissue findings in inclusion body myositis?

A

.

33
Q

What are the histologic findings in inclusion body myositis?

A

.

34
Q

Types of Myopathies

A

.

35
Q

What is rhabdomyolysis and some common features and etiologies?

A

.

36
Q

Causes of drug - induced myopathies

A

.

37
Q

Features of statin myopathies

A

.

38
Q

Features of steroid myopathies

A

.

39
Q

Features of metabolic myopathies

A

.

40
Q

Clinical presentation of metabolic myopathies

A

.

41
Q

List some primary metabolic myopathies

A

.

42
Q

List some secondary metabolic myopathies

A

.

43
Q

Presentation of Polymyalgia rheumatica

A

.

44
Q

Muscles, inflamatory markers and enzyme findings in PMR

A

.

45
Q

Treatment of PMR

A

.

46
Q

How to approach a patient with weakness

A

.